Bank of Nova Scotia’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $113M | Buy |
181,706
+84,186
| +86% | +$57.3M | 0.17% | 97 |
|
|
2026
Q1 | $75.3M | Sell |
97,520
-22,491
| -19% | -$17.2M | 0.13% | 134 |
|
|
2025
Q4 | $92.6M | Sell |
120,011
-158,540
| -57% | -$108M | 0.14% | 126 |
|
|
2025
Q3 | $157M | Buy |
278,551
+29,273
| +12% | +$16.6M | 0.28% | 63 |
|
|
2025
Q2 | $131M | Buy |
249,278
+126,689
| +103% | +$70.7M | 0.27% | 63 |
|
|
2025
Q1 | $77.7M | Buy |
122,589
+32,427
| +36% | +$22.3M | 0.17% | 103 |
|
|
2024
Q4 | $64.2M | Sell |
90,162
-8,529
| -9% | -$7.16M | 0.11% | 142 |
|
|
2024
Q3 | $104M | Buy |
98,691
+2,555
| +3% | +$2.84M | 0.21% | 80 |
|
|
2024
Q2 | $101M | Buy |
96,136
+70,928
| +281% | +$68.8M | 0.2% | 80 |
|
|
2024
Q1 | $24.3M | Sell |
25,208
-1,940
| -7% | -$1.84M | 0.05% | 239 |
|
|
2023
Q4 | $23.8M | Sell |
27,148
-24,320
| -47% | -$20M | 0.04% | 268 |
|
|
2023
Q3 | $42.4M | Buy |
51,468
+25,722
| +100% | +$20.2M | 0.11% | 153 |
|
|
2023
Q2 | $18.5M | Buy |
25,746
+18,055
| +235% | +$13.9M | 0.05% | 216 |
|
|
2023
Q1 | $6.32M | Sell |
7,691
-7,158
| -48% | -$5.4M | 0.02% | 347 |
|
|
2022
Q4 | $10.7M | Sell |
14,849
-12,993
| -47% | -$9.59M | 0.03% | 339 |
|
|
2022
Q3 | $19.2M | Sell |
27,842
-12,922
| -32% | -$8.13M | 0.06% | 228 |
|
|
2022
Q2 | $24.1M | Buy |
40,764
+25,994
| +176% | +$16.9M | 0.06% | 250 |
|
|
2022
Q1 | $10.3M | Sell |
14,770
-39,335
| -73% | -$24.9M | 0.02% | 444 |
|
|
2021
Q4 | $34.2M | Sell |
54,105
-69,070
| -56% | -$42.5M | 0.05% | 295 |
|
|
2021
Q3 | $74.5M | Sell |
123,175
-22,473
| -15% | -$14M | 0.13% | 153 |
|
|
2021
Q2 | $81.4M | Buy |
145,648
+125,015
| +606% | +$63.3M | 0.15% | 129 |
|
|
2021
Q1 | $9.76M | Buy |
20,633
+1,914
| +10% | +$932K | 0.02% | 409 |
|
|
2020
Q4 | $9.04M | Sell |
18,719
-39,575
| -68% | -$21.4M | 0.02% | 388 |
|
|
2020
Q3 | $32.6M | Buy |
58,294
+45,042
| +340% | +$27.3M | 0.09% | 197 |
|
|
2020
Q2 | $8.26M | Sell |
13,252
-51,894
| -80% | -$29.5M | 0.03% | 329 |
|
|
2020
Q1 | $31.8M | Sell |
65,146
-25,726
| -28% | -$10.6M | 0.11% | 168 |
|
|
2019
Q4 | $34.1M | Sell |
90,872
-31,241
| -26% | -$10.5M | 0.08% | 202 |
|
|
2019
Q3 | $33.9M | Buy |
122,113
+100,281
| +459% | +$29.7M | 0.1% | 183 |
|
|
2019
Q2 | $6.83M | Buy |
21,832
+4,420
| +25% | +$1.47M | 0.03% | 356 |
|
|
2019
Q1 | $7.15M | Buy |
17,412
+791
| +5% | +$326K | 0.03% | 364 |
|
|
2018
Q4 | $6.21M | Buy |
16,621
+853
| +5% | +$312K | 0.03% | 360 |
|
|
2018
Q3 | $6.37M | Sell |
15,768
-4,797
| -23% | -$1.83M | 0.03% | 384 |
|
|
2018
Q2 | $7.09M | Buy |
20,565
+10,750
| +110% | +$3.36M | 0.04% | 300 |
|
|
2018
Q1 | $3.38M | Sell |
9,815
-15,438
| -61% | -$5.37M | 0.02% | 456 |
|
|
2017
Q4 | $9.49M | Buy |
25,253
+11,909
| +89% | +$4.82M | 0.04% | 322 |
|
|
2017
Q3 | $5.97M | Sell |
13,344
-3,843
| -22% | -$1.83M | 0.03% | 341 |
|
|
2017
Q2 | $8.44M | Sell |
17,187
-230
| -1% | -$101K | 0.04% | 321 |
|
|
2017
Q1 | $6.75M | Buy |
17,417
+13,003
| +295% | +$4.82M | 0.03% | 349 |
|
|
2016
Q4 | $1.62M | Buy |
4,414
+2,829
| +178% | +$1.08M | 0.01% | 416 |
|
|
2016
Q3 | $637K | Sell |
1,585
-40,358
| -96% | -$16.2M | ﹤0.01% | 475 |
|
|
2016
Q2 | $14.6M | Buy |
41,943
+40,478
| +2,763% | +$15.6M | 0.09% | 119 |
|
|
2016
Q1 | $528K | Buy |
1,465
+20
| +1% | +$8.24K | ﹤0.01% | 465 |
|
|
2015
Q4 | $784K | Buy |
1,445
+8
| +0.6% | +$4.33K | ﹤0.01% | 427 |
|
|
2015
Q3 | $668K | Buy |
1,437
+117
| +9% | +$62.8K | ﹤0.01% | 373 |
|
|
2015
Q2 | $673K | Buy |
1,320
+61
| +5% | +$29.8K | ﹤0.01% | 322 |
|
|
2015
Q1 | $568K | Sell |
1,259
-81
| -6% | -$34.3K | ﹤0.01% | 341 |
|
|
2014
Q4 | $550K | Sell |
1,340
-17
| -1% | -$6.68K | ﹤0.01% | 346 |
|
|
2014
Q3 | $489K | Buy |
1,357
+100
| +8% | +$33.5K | ﹤0.01% | 366 |
|
|
2014
Q2 | $355K | Buy |
1,257
+125
| +11% | +$37K | ﹤0.01% | 414 |
|
|
2014
Q1 | $340K | Buy |
1,132
+18
| +2% | +$5.55K | ﹤0.01% | 437 |
|
|
2013
Q4 | $307K | Buy |
1,114
+171
| +18% | +$49.2K | ﹤0.01% | 459 |
|
|
2013
Q3 | $295K | Sell |
943
-168
| -15% | -$44.2K | ﹤0.01% | 417 |
|
|
2013
Q2 | $250K | Buy |
+1,111
| New | +$259K | ﹤0.01% | 425 |
|
Other funds holding REGN
Bank of Nova Scotia's REGN Position: Q2 2026 in Review
Bank of Nova Scotia increased its Regeneron Pharmaceuticals (REGN) stake by 86% in Q2 2026, buying an estimated $57.3M and bringing the position to 181,706 shares worth $113M. The position accounts for 0.17% of the portfolio, ranked #97.
Bank of Nova Scotia first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $157M in Q3 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Bank of Nova Scotia held 181,706 shares of Regeneron Pharmaceuticals worth $113M as of Q2 2026.
- Bank of Nova Scotia bought 84,186 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $57.3M.
- Regeneron Pharmaceuticals made up 0.17% of Bank of Nova Scotia's portfolio in Q2 2026, its #97 holding.
- Bank of Nova Scotia first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Nova Scotia's Regeneron Pharmaceuticals position peaked at $157M in Q3 2025.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.